| Literature DB >> 28203569 |
Stjepan Spalj1, Kate Mroz Tranesen2, Kari Birkeland3, Visnja Katic1, Andrej Pavlic1, Vaska Vandevska-Radunovic3.
Abstract
The purpose was to compare the treatment effects of functional appliances activator-headgear (AH) and Twin Block (TB) on skeletal, dental, and soft-tissue structures in class II division 1 malocclusion with normal growth changes in untreated subjects. The sample included 50 subjects (56% females) aged 8-13 years with class II division 1 malocclusion treated with either AH (n = 25) or TB (n = 25) appliances. Pre- and posttreatment lateral cephalograms were evaluated and compared to 50 untreated class II division 1 cases matched by age, gender, ANB angle, and skeletal maturity. A paired sample, independent samples tests and discriminant analysis were performed for intra- and intergroup analysis. Treatment with both appliances resulted in significant reduction of skeletal and soft-tissue facial convexity, the overjet, and the prominence of the upper lip in comparison to untreated individuals (p < 0.001). Retroclination of maxillary incisors and proclination of mandibular incisors were seen, the latter being significantly more evident in the TB group (p < 0.05). Increase of effective mandibular length was more pronounced in the TB group. In conclusion, both AH and TB appliances contributed successfully to the correction of class II division 1 malocclusion when compared to the untreated subjects with predominantly dentoalveolar changes.Entities:
Mesh:
Year: 2017 PMID: 28203569 PMCID: PMC5292161 DOI: 10.1155/2017/4861924
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Cephalometric variables used in the study.
| Number | Variable | Unit | Description |
|---|---|---|---|
| 1 | NSBa | ° | Cranial base angle expression of the flexion of the cranial base (nasion-sella-basion) |
| 2 | SNA | ° | Angle of anterior part of cranial base (S-N) and point A (subspinale) on maxilla |
| 3 | SNB | ° | Angle of anterior part of cranial base (S-N) and point B (supramentale) on mandible |
| 4 | ANB | ° | Angle between point nasion and point on maxilla and mandible, basal sagittal relation between the jaws |
| 5 | A-NPg | mm | The shortest distance from A point to the facial plane (N-Pg), expression of the skeletal convexity of the face |
| 6 | NL/NSL | ° | Angle between the nasal line (anterior to posterior nasal spine ANS-PNS) and the nasion-sella line, expression of the tilting of the maxilla relative to the anterior cranial base |
| 7 | MP/NSL | ° | Angle of mandibular plane (Go-Me) relative to the anterior cranial base |
| 8 | MP/NL | ° | Angle of mandibular plane (Go-Me) and nasal line |
| 9 | FA/NBa | ° | Lower angle between the facial axis (pterygoid point-gnathion) and the nasion-basion line, expression of the growth direction of the chin and the relationship, facial height and depth |
| 10 | UFH | mm | Upper facial height (middle third of the face), distance from nasion point to spina nasalis anterior measured perpendicular to Frankfort horizontal (FH) |
| 11 | LFH | mm | Lower facial height (lower third of the face), distance from spina nasalis anterior to menton measured perpendicular to FH |
| 12 | UFH/LFH | % | Upper to lower facial height ratio |
| 13 | Co-A | mm | Distance from condylion to A point; measurement of the effective length of midface |
| 14 | Co-Gn | mm | Distance from condylion to gnathion; measurement of the effective length of mandible |
| 15 | Max Mand diff | mm | Maxillomandibular differential length, the difference between the effective mandibular length (Co-Gn) and the effective midface length (Co-A): gives an indication of the sagittal discrepancy between maxilla and mandible |
| 16 | −1/MP | ° | Superoposterior angle of lower incisor long axis and mandibular plane |
| 17 | +1/NSL | ° | Inferoposterior angle of upper incisor long axis and a nasion-sella line |
| 18 | −1/A-Pg angle | ° | Angle between the long axis of the lower incisor and A-Pg line |
| 19 | +1/A-Pg angle | ° | Angle between the long axis of the upper incisor and A-Pg line |
| 20 | −1/A-Pg distance | mm | Distance from the midpoint of the incisal edge of the most prominent mandibular incisor to A-Pg line, expression of the protrusion of the lower incisors |
| 21 | +1/A-Pg distance | mm | Distance from the midpoint of the incisal edge of the most prominent maxillary incisor to A-Pg line, expression of the protrusion of the upper incisors |
| 22 | Gl′-Sn-Pg′ | ° | Lower angle formed by the line from glabella to subnasale and the line from soft tissue pogonion to subnasale, expression of the convexity of the soft tissue profile |
| 23 | Cm-Sn-Ls | ° | Nasolabial angle, expression of dentoalveolar protrusion |
| 24 | Li-E | mm | Distance from lower lip (labrale inferius) to Prn-Pg′ (Ricketts' Esthetic line) |
| 25 | Ls-E | mm | Distance from upper lip (labrale superius) to Prn-Pg′ (Ricketts' Esthetic line) |
| 26 | Li-S | mm | Distance from lower lip to Cm-Pg′ (Steiner's line) |
| 27 | Ls-S | mm | Distance from upper lip to Cm-Pg′ (Steiner's line) |
| 28 | OJ | mm | Distance between the incisal edges of the most prominent maxillary and mandibular incisors, measured parallel to the occlusal line |
Figure 1Points and plains used in cephalometric analysis: Gl′ (soft-tissue glabella), Prn (pronasale), Cm (columella), Sn (subnasale), Ls (labrale superius), Li (labrale inferius), Pg′ (soft-tissue pogonion), Pg (osseous pogonion), Gn (gnathion), Me (menton), Go (gonion), Ba (basion), Co (condylion), Po (porion), Pt (pterygoid point), S (sella), PNS (posterior nasal spine), ANS (anterior nasal spine), N (nasion), Or (orbitale), Ap + 1 (apicale superius), Ap − 1 (apicale inferius), In + 1 (incisale superius), In − 1 (incisale inferius), NSL (nasion-sella line), FA (facial axis), NL (nasal line), MP (mandibular plane), FH (Frankfort horizontal), E (Ricketts' Esthetic line), and S (Steiner's line).
Gender, age, and treatment duration of the Twin Block (TB), Activator headgear (AH) and untreated, control (CTRL) group.
| Treatment group |
| |||
|---|---|---|---|---|
| TB | AH | CTRL | ||
| Female gender ( | 15 (60) | 13 (52) | 28 (56) | 0.850 |
| Age before treatment (years) | ||||
| Median (interquartile range) | 11 (10–12) | 10 (9–11) | 11 (10-11) | 0.336 |
| Min–max | 9–13 | 8–12 | 8–13 | |
| Mean observation period (months) | ||||
| Mean ± std. deviation | 14.2 ± 4.8 | 15.4 ± 5.5 | 14.9 ± 5.2 | 0.745 |
| Min–max | 8–24 | 12–24 | 10–24 | |
χ 2 test. Kruskal-Wallis test. ANOVA.
Pretreatment (T1) and posttreatment (T2) values of the investigated variables in the Twin Block (TB) and activator-headgear (AH) groups.
| TB |
|
| AH |
|
| |||
|---|---|---|---|---|---|---|---|---|
| T1 | T2 | T1 | T2 | |||||
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |||||
| NSBa | 131.0 ± 4.5 | 130.9 ± 4.6 | 0.752 | 0.065 | 128.3 ± 5.1 | 127.4 ± 5.0 |
| 0.476 |
| SNA | 80.1 ± 3.2 | 79.8 ± 3.6 | 0.118 | 0.315 | 81.8 ± 2.8 | 81.7 ± 2.7 | 0.432 | 0.161 |
| SNB | 74.2 ± 3.0 | 75.3 ± 3.3 |
| 0.751 | 76.2 ± 2.5 | 77.4 ± 2.5 |
| 0.835 |
| ANB | 5.9 ± 1.6 | 4.4 ± 1.7 |
| 0.751 | 5.7 ± 1.7 | 4.2 ± 1.7 |
| 0.899 |
| A-NPg | 4.9 ± 2.1 | 3.7 ± 2.3 |
| 0.661 | 4.2 ± 2.2 | 2.9 ± 2.4 |
| 0.831 |
| NL/NSL | 7.9 ± 2.9 | 7.6 ± 3.1 | 0.359 | 0.187 | 5.4 ± 2.5 | 5.2 ± 2.6 | 0.420 | 0.165 |
| MP/NSL | 35.2 ± 4.7 | 35.3 ± 5.2 | 0.925 | 0.019 | 33.3 ± 5.0 | 32.4 ± 4.7 |
| 0.488 |
| MP/NL | 27.3 ± 4.5 | 27.7 ± 4.8 | 0.431 | 0.162 | 27.9 ± 4.6 | 27.2 ± 4.6 | 0.086 | 0.343 |
| FA/NBa | 86.1 ± 3.4 | 86.3 ± 3.7 | 0.614 | 0.104 | 87.5 ± 3.7 | 87.8 ± 4.0 | 0.299 | 0.212 |
| UFH | 47.7 ± 3.0 | 49.3 ± 3.4 |
| 0.597 | 46.2 ± 4.8 | 46.7 ± 3.3 | 0.534 | 0.128 |
| LFH | 56.8 ± 4.5 | 59.9 ± 4.7 |
| 0.784 | 57.3 ± 5.7 | 58.8 ± 4.4 | 0.154 | 0.288 |
| UFH/LFH | 84.4 ± 8.0 | 82.8 ± 7.2 |
| 0.474 | 80.7 ± 4.9 | 79.6 ± 5.3 | 0.157 | 0.286 |
| Co-A | 81.0 ± 5.3 | 83.0 ± 4.3 |
| 0.467 | 83.0 ± 8.2 | 82.6 ± 4.2 | 0.799 | 0.053 |
| Co-Gn | 99.9 ± 6.1 | 105.0 ± 6.3 |
| 0.768 | 102.6 ± 10.4 | 105.1 ± 6.0 | 0.162 | 0.283 |
| Max Mand diff | 18.9 ± 3.1 | 22.0 ± 4.3 |
| 0.743 | 19.6 ± 3.6 | 22.4 ± 3.5 |
| 0.784 |
| −1/MP | 97.7 ± 7.4 | 100.7 ± 7.4 |
| 0.572 | 95.5 ± 7.6 | 96.1 ± 6.4 | 0.456 | 0.153 |
| +1/NSL | 107.6 ± 7.1 | 100.5 ± 6.4 |
| 0.803 | 110.1 ± 6.7 | 102.7 ± 6.3 |
| 0.772 |
| −1/A-Pg angle | 22.0 ± 5.8 | 27.5 ± 5.2 |
| 0.765 | 21.0 ± 7.3 | 23.7 ± 5.1 |
| 0.583 |
| +1/A-Pg angle | 38.5 ± 5.5 | 28.9 ± 4.7 |
| 0.893 | 37.9 ± 5.6 | 27.5 ± 5.2 |
| 0.867 |
| −1/A-Pg distance | 0.3 ± 2.0 | 2.6 ± 1.7 |
| 0.875 | 0.0 ± 2.3 | 1.4 ± 2.0 |
| 0.775 |
| +1/A-Pg distance | 9.3 ± 1.9 | 6.4 ± 1.9 |
| 0.915 | 9.2 ± 2.0 | 5.6 ± 2.0 |
| 0.861 |
| Gl′-Sn-Pg′ | 20.3 ± 5.3 | 18.2 ± 5.6 |
| 0.583 | 18.5 ± 5.8 | 16.4 ± 5.2 |
| 0.586 |
| Cm-Sn-Ls | 116.9 ± 11.9 | 118.1 ± 10.2 | 0.589 | 0.111 | 107.7 ± 8.5 | 113.8 ± 11.3 |
| 0.533 |
| Li-E | 0.1 ± 2.5 | −0.5 ± 2.5 | 0.120 | 0.313 | −0.6 ± 3.5 | −1.5 ± 2.8 |
| 0.455 |
| Ls-E | −0.5 ± 2.0 | −2.2 ± 2.0 |
| 0.701 | −0.1 ± 2.2 | −1.9 ± 2.4 |
| 0.823 |
| Li-S | 1.1 ± 2.4 | 0.7 ± 2.3 | 0.327 | 0.200 | 0.7 ± 3.3 | −0.1 ± 2.8 | 0.050 | 0.389 |
| Ls-S | 1.3 ± .7 | −0.2 ± 1.6 |
| 0.661 | 2.0 ± 2.0 | 0.1 ± 2.2 |
| 0.861 |
| OJ | 9.0 ± 2.5 | 3.8 ± 1.8 |
| 0.956 | 9.2 ± 2.3 | 4.3 ± 1.9 |
| 0.888 |
Paired samples t-test.
Effect size calculated by using the formula r = √t2/(t2 + df). Cohen criteria for interpretation of effect size were used: r = 0.1–0.3 = small effect size, 0.3–0.5 = medium, and >0.5 = large.
Mean values of the investigated variables in the untreated, control group at the same pretreatment (T1) and posttreatment (T2) age as the treated groups.
| T1 | T2 |
|
| |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | |||
| NSBa | 130.9 ± 4.2 | 130.7 ± 4.7 | 0.514 | 0.093 |
| SNA | 82.1 ± 2.4 | 82.4 ± 2.5 | 0.174 | 0.193 |
| SNB | 75.8 ± 2.8 | 76.3 ± 2.6 |
| 0.384 |
| ANB | 6.3 ± 2.0 | 6.0 ± 1.9 | 0.204 | 0.181 |
| A-NPg | 5.2 ± 2.0 | 5.1 ± 2.1 | 0.479 | 0.101 |
| NL/NSL | 6.6 ± 3.3 | 6.7 ± 3.5 | 0.772 | 0.042 |
| MP/NSL | 35.0 ± 4.8 | 34.9 ± 5.0 | 0.625 | 0.070 |
| MP/NL | 28.4 ± 5.0 | 28.2 ± 5.3 | 0.526 | 0.091 |
| FA/NBa | 87.9 ± 4.3 | 88.2 ± 4.2 | 0.304 | 0.147 |
| UFH | 46.3 ± 3.1 | 47.6 ± 3.4 |
| 0.581 |
| LFH | 56.5 ± 5.2 | 57.9 ± 6.0 |
| 0.463 |
| UFH/LFH | 82.3 ± 6.6 | 82.8 ± 7.3 | 0.535 | 0.089 |
| Co-A | 81.3 ± 4.9 | 82.7 ± 5.3 |
| 0.512 |
| Co-Gn | 99.8 ± 5.9 | 102.4 ± 6.4 |
| 0.761 |
| Max Mand diff | 18.5 ± 3.2 | 19.7 ± 4.0 |
| 0.461 |
| −1/MP | 97.8 ± 5.5 | 96.9 ± 5.5 | 0.105 | 0.230 |
| +1/NSL | 102.7 ± 7.2 | 103.1 ± 7.2 | 0.487 | 0.100 |
| −1/A-Pg angle | 22.7 ± 5.1 | 22.5 ± 5.2 | 0.708 | 0.054 |
| +1/A-Pg angle | 32.8 ± 6.7 | 32.4 ± 6.8 | 0.345 | 0.135 |
| −1/A-Pg distance | 1.3 ± 2.3 | 1.2 ± 2.4 | 0.749 | 0.046 |
| +1/A-Pg distance | 6.9 ± 2.2 | 7.1 ± 2.7 | 0.144 | 0.207 |
| Gl′-Sn-Pg′ | 16.4 ± 4.4 | 16.8 ± 4.3 | 0.258 | 0.161 |
| Cm-Sn-Ls | 110.0 ± 13.9 | 112.9 ± 9.6 |
| 0.293 |
| Li-E | 1.4 ± 2.2 | 1.1 ± 2.3 | 0.270 | 0.157 |
| Ls-E | 0.4 ± 2.2 | −0.1 ± 2.1 |
| 0.334 |
| Li-S | 2.3 ± 2.2 | 2.2 ± 2.3 | 0.783 | 0.039 |
| Ls-S | 2.1 ± 2.0 | 2.0 ± 2.2 | 0.829 | 0.031 |
| OJ | 5.6 ± 2.1 | 5.9 ± 2.2 | 0.068 | 0.258 |
Paired samples t-test.
Effect size.
Comparison of the treatment changes (Δ) in the Twin Block (TB) and activator-headgear (AH) group and untreated controls (CTRL).
| ΔTB | ΔAH | ΔCTRL |
|
| |
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | |||
| NSBa | −0.1 ± 2.1 | −0.9 ± 1.6 | −0.2 ± 2.1 | 0.313 | 0.024 |
| SNA | −0.4 ± 1.2 | −0.2 ± 1.2 | 0.3 ± 1.5 | 0.087 | 0.049 |
| SNB | 1.1 ± 1.0 | 1.2 ± 0.8 | 0.6 ± 1.3 |
| 0.066 |
| ANB | −1.5 ± 1.3a | −1.4 ± 0.7a | −0.3 ± 1.5b |
| 0.179 |
| A-NPg | −1.2 ± 1.3a | −1.3 ± 0.9a | −0.1 ± 1.4b |
| 0.161 |
| NL/NSL | −0.4 ± 1.9 | −0.3 ± 1.6 | 0.1 ± 2.1 | 0.588 | 0.011 |
| MP/NSL | −0.0 ± 1.7 | −0.9 ± 1.7 | −0.1 ± 2.1 | 0.138 | 0.040 |
| MP/NL | 0.4 ± 2.4 | −0.7 ± 1.9 | −0.2 ± 2.6 | 0.283 | 0.026 |
| FA/NBa | 0.2 ± 2.0 | 0.3 ± 1.5 | 0.3 ± 2.0 | 0.976 | 0.001 |
| UFH | 1.6 ± 2.2 | 0.5 ± 4.0 | 1.3 ± 1.9 | 0.295 | 0.025 |
| LFH | 3.0 ± 2.4 | 1.5 ± 5.1 | 1.4 ± 2.6 | 0.119 | 0.043 |
| UFH/LFH | −1.7 ± 3.2 | −1.1 ± 3.8 | 0.5 ± 5.8 | 0.134 | 0.041 |
| Co-A | 2.0 ± 3.9 | −0.3 ± 6.7 | 1.4 ± 2.4 | 0.114 | 0.044 |
| Co-Gn | 5.1 ± 4.4 | 2.5 ± 8.6 | 2.6 ± 2.2 | 0.086 | 0.049 |
| Max Mand diff | 3.1 ± 2.9a | 2.8 ± 2.3a | 1.1 ± 2.2b |
| 0.126 |
| −1/MP | 3.0 ± 4.4a | 0.5 ± 3.6b | −0.9 ± 3.8b |
| 0.145 |
| +1/NSL | −7.0 ± 5.3a | −7.3 ± 6.2a | 0.4 ± 4.0b |
| 0.378 |
| −1/A-Pg angle | 5.5 ± 4.8a | 2.7 ± 3.8b | −0.2 ± 3.3c |
| 0.283 |
| +1/A-Pg angle | −9.6 ± 4.9a | −10.4 ± 6.1a | −0.5 ± 3.4b |
| 0.528 |
| −1/A-Pg distance | 2.3 ± 1.3a | 1.3 ± 1.1b | −0.1 ± 1.2c |
| 0.416 |
| +1/A-Pg distance | −2.9 ± 1.3a | −3.6 ± 2.2a | 0.2 ± 1.1b |
| 0.592 |
| Gl′-Sn-Pg′ | −2.1 ± 3.0a | −2.0 ± 2.9a | 0.4 ± 2.3b |
| 0.182 |
| Cm-Sn-Ls | 1.2 ± 11.0 | 6.1 ± 10.0 | 2.9 ± 9.5 | 0.207 | 0.032 |
| Li-E | −0.6 ± 1.8 | −0.9 ± 1.9 | −0.3 ± 1.6 | 0.290 | 0.025 |
| Ls-E | −1.8 ± 1.8a | −1.8 ± 1.3a | −0.4 ± 1.2b |
| 0.205 |
| Li-S | −0.4 ± 1.8 | −0.8 ± 2.0 | −0.1 ± 1.6 | 0.212 | 0.032 |
| Ls-S | −1.5 ± 1.7a | −1.9 ± 1.1a | −0.0 ± 1.4b |
| 0.261 |
| OJ | −5.2 ± 1.6a | −4.9 ± 2.6a | 0.3 ± 1.2b |
| 0.712 |
ANOVA with Student-Newman-Keuls post hoc tests. Groups in the same row that share the same superscript letter do not differ significantly.
Effect size calculated according to formula: η2 = between groups sum of squares/total sum of squares. Cohen criteria for interpretation of effect size were used: η2 = 0.02–0.13 = small effect size, 0.13–0.26 = medium, and >0.26 = large.
Figure 2Canonical discriminant functions graph.
Structural matrix of canonical discriminant functions.
| Function | ||
|---|---|---|
| 1 | 2 | |
| Δ+1/A-Pg distance | −0.699 | −0.394 |
| Δ−1/A-Pg distance | 0.476 | −0.453 |
| Δ+1/NSL | −0.458 | −0.108 |
| ΔLs-E | −0.298 | −0.076 |
| ΔGl′-Sn-Pog′ | −0.277 | −0.025 |
| ΔANB | −0.275 | −0.008 |
| ΔSNB | 0.153 | 0.112 |
| ΔSNA | −0.131 | 0.087 |
| ΔUFH/LFH | −0.120 | 0.062 |
| Δ−1/MP | 0.210 | −0.387 |
| ΔCo-A | −0.034 | −0.383 |
| ΔMP/NSL | −0.045 | −0.351 |
| ΔCo-Gn | 0.080 | −0.340 |
| ΔLi-E | −0.082 | −0.150 |
Largest absolute correlation between each variable and any discriminant function. Variables ordered by absolute size of correlation within function.